Advance of promising targets and agents against COVID-19 in China

MeSH terms

• Adenine / analogs & derivatives
• Adenine / therapeutic use
• Adenosine Monophosphate / analogs & derivatives
• Adenosine Monophosphate / therapeutic use
• Alanine / analogs & derivatives
• Alanine / therapeutic use
• Amides / therapeutic use
• Antimalarials / therapeutic use
• Antiviral Agents / therapeutic use*
• Betacoronavirus / metabolism*
• COVID-19
• COVID-19 Drug Treatment
• China
• Chloroquine / therapeutic use
• Clinical Trials as Topic
• Cobicistat / therapeutic use
• Coronavirus 3C Proteases
• Coronavirus Infections / drug therapy*
• Cysteine Endopeptidases / metabolism
• Dibenzothiepins
• Drug Combinations
• Drug Discovery
• Drug Therapy, Combination
• Emtricitabine / therapeutic use
• Humans
• Hydroxychloroquine / therapeutic use
• Indoles / therapeutic use
• Lopinavir / therapeutic use
• Medicine, Chinese Traditional
• Morpholines
• Oseltamivir / therapeutic use
• Oxazines / therapeutic use
• Pandemics
• Pneumonia, Viral / drug therapy*
• Pyrazines / therapeutic use
• Pyridines / therapeutic use
• Pyridones
• RNA-Dependent RNA Polymerase / metabolism
• Ritonavir / therapeutic use
• SARS-CoV-2
• Spike Glycoprotein, Coronavirus / metabolism
• Tenofovir / therapeutic use
• Thiepins / therapeutic use
• Triazines / therapeutic use
• Viral Nonstructural Proteins / metabolism